A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation
British Journal of Cancer 116, 1279 (9 May 2017). doi:10.1038/bjc.2017.109
Authors: M A Calegari, A Inno, S Monterisi, A Orlandi, D Santini, M Basso, A Cassano, M Martini, T Cenci, I de Pascalis, F Camarda, B Barbaro, L M Larocca, S Gori, G Tonini & C Barone
http://ift.tt/2oWwnln
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου